- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03895060
Vertical and Horizontal Alveolar Ridge Augmentation Using Autogenous Onlay Blocks Combined With Guided Bone Regeneration Using Native Collagen Membrane in Atrophic Anterior Maxilla.
March 28, 2019 updated by: Reham Moemen Abdel Salam Dewedar, Cairo University
Vertical and Horizontal Alveolar Ridge Augmentation Using Autogenous Onlay Ring Blocks Combined With Simultaneous Guided Bone Regeneration Using Native Collagen Membrane in Atrophic Anterior Maxilla.
Many different techniques exist for effective vertical bone augmentation, such as the use of particulate bone grafts and bone graft substitutes, barrier membranes for guided bone regeneration (GBR), autogenous and allogenic block grafts, and the application of distraction osteogenesis.
Harvesting of autogenous block grafts is associated with greater morbidity compared with the less invasive procedure of using autogenous particles harvested through bone scrapers.
On the other hand, particulate grafts always require a space-maintaining barrier, or their physical properties would not allow three-dimensional bone regeneration as those of block grafts do.
Study Overview
Status
Unknown
Intervention / Treatment
Detailed Description
An autogenous ring block is harvested from the chin area by trephine bur and the autogenous bone chips will be collected with a bone scraper, then a specially manufactured machine titanium tenting screw is used to fasten the ring block to the alveolar ridge.
Two or three ring blocks is screwed according to the defect.
Then resorbable collagen membrane is fixed to the alveolar ridge instead of the titanium-reinforced e-PTFE and equally autogenous and xenograft bone particles is packed around the screw to fill the defect area completely.
Extreme care is taken to avoid autogenous particles drifting distally toward the area of the block.
The barrier membrane was then closed over the block and particulate graft and fixed by bone tacks.
Then periosteal releasing incision is done to allow tension free adaption of the mucoperisteal flap.
Study Type
Interventional
Enrollment (Anticipated)
10
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
25 years to 60 years (Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Patients with partially edentulous in the anterior area of the maxilla, with a residual ridge that allowed insertion of ≤11.5 mm length implants.
- Both sexes.
- No intraoral soft and hard tissue pathology
- No systemic condition that contraindicate implant placement.
Exclusion Criteria:
- Pathology.
- Heavy smokers more than 20 cigarettes per day.
- Patients with systemic disease that may affect normal healing.
- Psychiatric problems
- Disorders to implant are related to history of radiation therapy to the head and neck neoplasia, or bone augmentation to implant site
- Immunodeficiency pathology, bruxism, stress situation (socially or professionally), emotional instability, and unrealistic aesthetic demands.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: autogenous ring blockls with GBR covered by collagen membrane
Vertical and horizontal ridge augmentation using autogenous onlay ring blocks combined with simultaneous guided bone regeneration using native collagen membrane in atrophic anterior maxilla.
|
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Bone gained vertically
Time Frame: 6 months
|
Amount of bone gained vertically will be measured using CBCT
|
6 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Anticipated)
April 1, 2019
Primary Completion (Anticipated)
March 1, 2020
Study Completion (Anticipated)
March 30, 2020
Study Registration Dates
First Submitted
March 28, 2019
First Submitted That Met QC Criteria
March 28, 2019
First Posted (Actual)
March 29, 2019
Study Record Updates
Last Update Posted (Actual)
March 29, 2019
Last Update Submitted That Met QC Criteria
March 28, 2019
Last Verified
March 1, 2019
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- MOI CairoU
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Anterior Maxilla With Deficient Ridge Height and/or Width
-
Tanta UniversityCompletedPosterior Mandible With Deficient Ridge WidthEgypt
-
Tanta UniversityCompletedPosterior Mandible With Deficient Ridge HeightEgypt
-
Cairo UniversityUnknownPosterior Mandible With Deficient Ridge Height
-
University Hospital of CologneUnknownPosterior Maxilla Edentulous Patients With Insufficient Alveolar Bone Height
-
Cairo UniversityUnknownAugmentation of Maxillary Horizontal And Vertical Bone Deficiency Using Mineralized Plasmatic MatrixAlveolar Ridge Abnormality of MaxillaEgypt
-
Ikena OncologyTerminatedSolid Tumor | Solid Tumors, Adult | Malignant Pleural Mesothelioma (MPM) | Epithelioid Hemangioendothelioma (EHE) | NF2 Deficient Mesothelioma | NF2 Deficiency | YAP1 or TAZ Gene Fusions | Other NF2 Deficient Solid Tumors and Solid Tumors with YAP1/TAZ Fusion GenesUnited States, United Kingdom, Australia
-
Dana-Farber Cancer InstituteGateway for Cancer ResearchActive, not recruitingEpithelioid Sarcoma | Atypical Teratoid/Rhabdoid Tumor | Malignant Rhabdoid Tumor | Rhabdoid Tumor of the Kidney | Chordoma (Poorly Differentiated or De-differentiated) | Other INI1 Negative Tumors (With PI Approval) | Other SMARCA4-deficient Malignant Tumors (With PI Approval)United States
-
Assistance Publique - Hôpitaux de ParisURC-CIC Paris Descartes Necker CochinRecruitingArtemis (DCLRE1C ) Deficient Severe Combined ImmunodeficiencyFrance
-
Aalborg University HospitalAarhus University Hospital; Danish Cancer Society; Vejle HospitalRecruitingLow Anterior Resection Syndrome | Faecal Incontinence | Faecal Incontinence With Faecal Urgency | Colorectal (Colon or Rectal) Cancer SurvivorsDenmark
-
NYU Langone HealthBristol-Myers SquibbCompletedFemale Patients With Behcet's SyndromeUnited States
Clinical Trials on autogenous ring blockls with GBR covered by collagen membrane
-
Cairo UniversityRecruiting
-
Universitat Internacional de CatalunyaRecruitingBone ResorptionSpain
-
Cairo UniversityRecruiting
-
Future University in EgyptCompleted
-
Merna Nasser Mohamed Mostafa Ibrahim ElnahasCompleted